Mark Jacobson | COO |
Herriot Tabuteau | Chairman & CEO |
Nick Pizzie | CFO |
Lori Englebert | EVP, Commercial and Business Development |
Hunter Murdock | General Counsel |
Charles Duncan | Cantor Fitzgerald |
Marc Goodman | SVB Securities |
Vikram Purohit | Morgan Stanley |
Jason Gerberry | Bank of America |
David Amsellem | Piper Sandler |
Joon Lee | Truist Securities |
Joseph Thome | Cowen & Company |
David Hoang | SMBC |
Eddie Hickman | Guggenheim Partners |
Graig Suvannavejh | Mizuho Securities |
Robert Hazlett | BTIG |
Myles Minter | William Blair |
Matthew Kaplan | Ladenburg Thalmann |
Good morning, and welcome to the Axsome Therapeutics Conference Call. Currently, all participants are in listen-only mode. Later, there will be a question-and-answer session, and instructions will follow at that time. [Operator Instructions] As a reminder, today's conference is being recorded.
I would now like to turn the conference over to your host, Mark Jacobson, Chief Operating Officer at Axsome Therapeutics.